Bio-Rad Laboratories, Inc. which can be found using ticker (BIO) have now 5 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 605 and 525 calculating the average target price we see $569.20. Given that the stocks previous close was at $381.75 this is indicating there is a potential upside of 49.1%. There is a 50 day moving average of $454.34 and the 200 moving average now moves to $448.62. The company has a market cap of 11.34B. The stock price is currently at: 384.67 USD
The potential market cap would be $16,901,025,675 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 93.57 and a 1.86% return on assets.
